0       0

Clinical Nutrition Week 2016


T34 - Parenteral Nutrition Formulation Conundrum


Jan 19, 2016 1:30pm ‐ Jan 19, 2016 3:00pm

Standard: $39.00
Members: $19.00

Description

Objectives:

  1. Describe the risks and benefits of compounding PN solutions as 3-in-1 versus 2-in-1 admixtures in various populations
  2. Identify factors affecting stability of 3-in-1 PN solutions and recognized conditions that may lead to destabilization
  3. Evaluate the risks and benefits of using pre-mixed PN versus individualized PN admixtures for a given patient or facility
  4. List the current recommendations from the CDC, the A.S.P.E.N. PN Safety Consensus recommendations, and current literature regarding the repackaging of IVFE and their appropriate hang times
  5. Explain the rationale for repackaging IVFE in the neonatal population

Speaker(s):

  • Sara E. Bliss, PharmD, BCPS, BCNSP, Clinical Pharmacist, Surgery/Nutrition Support, Wake Forest University Baptist Medical Center, Winston-Salem, NC
  • Carol Rollins, PharmD, MS, RD, BCNSP, FASHP, FASPEN, Clinical Professor, Pharmacy Practice and Science, University of Arizona College of Pharmacy, Tucson, AZ
  • Amber J. Verdell, PharmD, BCPS, BCNSP, CNSC, Pharmacist, Olive View-UCLA Medical Center, Pasadena, CA

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content